IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v25y2024i2d10.1007_s10198-023-01585-8.html
   My bibliography  Save this article

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort

Author

Listed:
  • Isabella Vanorio-Vega

    (Caisse Nationale de L’assurance Maladie (CNAM)
    Agence de la Biomédecine)

  • Panayotis Constantinou

    (Caisse Nationale de L’assurance Maladie (CNAM))

  • Victor Bret

    (Caisse Nationale de L’assurance Maladie (CNAM))

  • Stéphanie Gentile

    (Aix Marseille University)

  • Patrik Finne

    (University of Helsinki and Helsinki University Hospital)

  • Bénédicte Sautenet

    (Transplantation Rénale INSERM U1246 SPHERE)

  • Philippe Tuppin

    (Caisse Nationale de L’assurance Maladie (CNAM))

  • Cécile Couchoud

    (Agence de la Biomédecine)

Abstract

End-stage kidney disease (ESKD) is associated with a substantial economic burden. In France, the cost of care for such patients represents 2.5% of the total French healthcare expenditures but serves less than 1% of the population. These patients’ healthcare expenditures are high because of the specialized and complex treatment needed as well as the presence of multiple comorbidities. This study aims to describe and assess the effect of comorbidities on healthcare expenditures (direct medical cost and non-medical costs including transportation and compensatory allowances) for patients with ESKD in France while considering the modality and duration of renal replacement therapy (RRT). This study included adults who started RRT for the first time between 2012 and 2014 in France and were followed for 5 years. Generalized linear models were built to predict mean monthly cost (MMC) by integrating first the time duration in the cohort, then patient characteristics and finally the duration of use of each treatment modalities. Comorbidities with the highest effect on MMC were inability to walk (+ 1435€), active cancer (+ 593€), HIV positivity (+ 507€) and diabetes (+ 396€). These effects vary according to age or treatment modalities. This study confirms the importance of considering patient characteristics, comorbidities and type of RRT when assessing healthcare expenditures for patients with ESKD.

Suggested Citation

  • Isabella Vanorio-Vega & Panayotis Constantinou & Victor Bret & Stéphanie Gentile & Patrik Finne & Bénédicte Sautenet & Philippe Tuppin & Cécile Couchoud, 2024. "Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(2), pages 269-279, March.
    • Handle: RePEc:spr:eujhec:v:25:y:2024:i:2:d:10.1007_s10198-023-01585-8
    DOI: 10.1007/s10198-023-01585-8
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-023-01585-8
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10198-023-01585-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:25:y:2024:i:2:d:10.1007_s10198-023-01585-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.